Because in-patent pharmaceuticals are a LOT more expensive than out of patent ones their monetary value is far greater than the greater volume of out of patent pharmaceuticals. If you look at where big pharma makes its revenues and their sales relative to generics sellers you can see this. Because of that the cost of making them is not really that important.

As for aircraft, not that many in number, but very expensive things with very expensive parts.